MedPath

Ciprofol

Generic Name
Ciprofol
Indication

用于消化道内镜检查中的镇静、支气管镜检查中的镇静以及全身麻醉诱导。

A Study Evaluating the Mass Balance of [14C]HSK3486 Emulsion Injection in Healthy Adults.

Phase 1
Completed
Conditions
Anesthesia
Sedation
Interventions
First Posted Date
2018-11-23
Last Posted Date
2019-10-28
Lead Sponsor
Sichuan Haisco Pharmaceutical Group Co., Ltd
Target Recruit Count
6
Registration Number
NCT03751956
Locations
🇨🇳

the First Affilicated Hospital of Soochow University, Suzhou, China

A Study Evaluating the Mass Balance of Micro-dose[14C]HSK3486 Emulsion Injection in Healthy Adults

Phase 1
Withdrawn
Conditions
Anesthesia
Sedation
Interventions
First Posted Date
2018-11-23
Last Posted Date
2022-06-02
Lead Sponsor
Sichuan Haisco Pharmaceutical Group Co., Ltd
Registration Number
NCT03751969

A Study Evaluating the Safety and Pharmacokinetics/Pharmacodynamics of HSK3486

Phase 1
Completed
Conditions
Anesthesia
Sedation
Interventions
First Posted Date
2018-11-19
Last Posted Date
2020-01-09
Lead Sponsor
Sichuan Haisco Pharmaceutical Group Co., Ltd
Target Recruit Count
16
Registration Number
NCT03745625
Locations
🇨🇳

West China Hospital,Sichuan University, Chengdu, China

A Study Evaluating the Efficacy and Safety of HSK3486

Phase 2
Completed
Conditions
Sedation and Anesthesia for Adult Colonoscopy Procedures
Interventions
First Posted Date
2018-10-17
Last Posted Date
2018-10-18
Lead Sponsor
Sichuan Haisco Pharmaceutical Group Co., Ltd
Target Recruit Count
94
Registration Number
NCT03709056
Locations
🇨🇳

Shanghai Fengxian District Central Hospital, Shanghai, China

🇨🇳

West China Hospital, Sichuan University, Changde, China

🇨🇳

The Third Xiangya Hospital of Central South University, Changsha, China

and more 5 locations

A Phase IIa Study Investigating the Tolerance, Efficacy and Safety of HSK3486

Phase 2
Completed
Conditions
Induction of General Anaesthesia
Interventions
First Posted Date
2018-10-09
Last Posted Date
2018-10-09
Lead Sponsor
Sichuan Haisco Pharmaceutical Group Co., Ltd
Target Recruit Count
114
Registration Number
NCT03698617
Locations
🇨🇳

The 2nd Affiliated Hospital of WMU, Wenzhou, Zhejiang, China

A Phase III Study Evaluating The Efficacy and Safety of HSK3486 for Sedation or Anesthesia

Phase 3
Completed
Conditions
Sedation or Anesthesia
Interventions
First Posted Date
2018-09-17
Last Posted Date
2019-07-05
Lead Sponsor
Sichuan Haisco Pharmaceutical Group Co., Ltd
Target Recruit Count
280
Registration Number
NCT03674008
Locations
🇨🇳

West China Hospital, Sichuan University, Changde, China

© Copyright 2025. All Rights Reserved by MedPath